Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$541K Sell
8,584
-225
-3% -$14.6K 0.16% 52
2016
Q2
$545K Hold
8,809
0.17% 51
2016
Q1
$503K Hold
8,809
0.16% 51
2015
Q4
$522K Sell
8,809
-16
-0.2% -$922 0.17% 56
2015
Q3
$480K Buy
8,825
+13
+0.1% +$846 0.17% 53
2015
Q2
$592K Hold
8,812
0.22% 47
2015
Q1
$516K Sell
8,812
-94
-1% -$5.68K 0.18% 51
2014
Q4
$583K Hold
8,906
0.2% 49
2014
Q3
$514K Hold
8,906
0.19% 48
2014
Q2
$502K Buy
8,906
+320
+4% +$16.8K 0.18% 42
2014
Q1
$441K Sell
8,586
-343
-4% -$17.3K 0.17% 47
2013
Q4
$471K Sell
8,929
-1,263
-12% -$62.1K 0.19% 45
2013
Q3
$455K Hold
10,192
0.2% 44
2013
Q2
$421K Buy
+10,192
New +$446K 0.19% 44

Other funds holding ABBV

Acadia Trust's ABBV Position: Q3 2016 in Review

Acadia Trust reduced its AbbVie (ABBV) stake by 2.6% in Q3 2016, selling an estimated $14.6K and leaving 8,584 shares worth $541K. The position accounts for 0.16% of the portfolio, ranked #52.

Acadia Trust first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $592K in Q2 2015. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

  • Acadia Trust held 8,584 shares of AbbVie worth $541K as of Q3 2016.
  • Acadia Trust sold 225 AbbVie shares in Q3 2016, an estimated $14.6K.
  • AbbVie made up 0.16% of Acadia Trust's portfolio in Q3 2016, its #52 holding.
  • Acadia Trust first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
  • Acadia Trust's AbbVie position peaked at $592K in Q2 2015.
  • 1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Acadia Trust's 13F filing for Q3 2016, filed 15 Nov 2016.